The Venture Codex Logo

The Venture Codex

Cancer Focus Fund

2031 Kings Highway, Shreveport, LA, 71103, United States

Overview

Investment firm providing financial services focused on cancer research.

Founded

2019

Deals · 12mo

2

Links

WebsiteLinkedIn

Stage focus

Series A

Geographic focus

Germany
Israel
United States

Sector focus

Finance
Financial Services

Investment portfolio

6rounds
NAMEDATESIZE
Starget Pharma
Feb 2026Participated
$18 MSeries A
KAHR medical
Jan 2026Led
$32 MOther Equity
Eisbach Bio
Mar 2024Led
$5 MOther Equity
March Biosciences
Nov 2023Led
$5 MOther Equity
ImmunoGenesis
Jun 2023Led
$5 MOther Equity
Nectin Therapeutics
Mar 2022Led
$5 MOther Equity
Starget Pharma
Feb 2026Participated
$18 MSeries A
KAHR medical
Jan 2026Led
$32 MOther Equity
Eisbach Bio
Mar 2024Led
$5 MOther Equity
March Biosciences
Nov 2023Led
$5 MOther Equity
ImmunoGenesis
Jun 2023Led
$5 MOther Equity
Nectin Therapeutics
Mar 2022Led
$5 MOther Equity
6
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Cancer Focus Fund: 6 funding rounds are recorded in the selected participation categories.All available history.
Cancer Focus Fund: 6 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A01
Other Equity50

Monthly Deal Activity

Cancer Focus Fund: 6 deals are recorded across 56 months.All available history.
Cancer Focus Fund: 6 deals are recorded across 56 months. All available history
MonthDeals
Mar '221
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '231
Jul '230
Aug '230
Sep '230
Oct '230
Nov '231
Dec '230
Jan '240
Feb '240
Mar '241
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '261
Feb '261
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Cancer Focus Fund: Health & Life Sciences is the largest displayed sector by deal count (6 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Cancer Focus Fund: Health & Life Sciences is the largest displayed sector by deal count (6 deals). All available history
SectorDeals
Health & Life Sciences6

Deal Size Distribution

Cancer Focus Fund: 6 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Cancer Focus Fund: 6 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M3
$5M-$10M1
$10M-$25M1
$25M-$50M1
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Cancer Focus Fund: Israel has the largest recorded deal count among the displayed regions (3 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

Cancer Focus Fund: Israel has the largest recorded deal count among the displayed regions (3 deals). All available history
RegionDeals
Israel3
United States2
Europe1
Cancer Focus Fund: 8 co-investors are shown, with aMoon sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Cancer Focus Fund: 8 co-investors are shown, with aMoon sharing 1 recorded deals. All available history
Co-investorShared deals
aMoon1
BRF1
Flerie Invest1
Ilex Medical1
Louisiana Economic Development1
Oriella1
Peregrine Ventures1
SPRIM Global Investments1

Investment Strategy

Cancer Focus Fund: Led accounts for 83% and participating for 17% of round participation.All available history.
Cancer Focus Fund: Led accounts for 83% and participating for 17% of round participation. All available history
CategoryDeals (count)Share (%)
Led583%
Participating117%
Cancer Focus Fund: Single-lead accounts for 80% and co-led for 20% of lead dynamics.All available history.
Cancer Focus Fund: Single-lead accounts for 80% and co-led for 20% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead480%
Co-led120%

Team

Ross Barrett

Founder